Skip to content

NMT EasyFit Sensor and Cable

Evaluate Functionality and Use of the NMT EasyFit Sensor and NMT EasyFit Cable

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07394140
Enrollment
30
Registered
2026-02-06
Start date
2026-06-18
Completion date
2026-12-31
Last updated
2026-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Blockade Monitoring, NMT

Brief summary

The purpose of this clinical study is to collect and assess feedback from clinical users regarding the functionality and device use and collection of raw parameter date from the NMT Sensor and NMT Cable.

Detailed description

The NMT Sensor provides quantitative, automated measurements of neuromuscular block by delivering non-invasive electrical stimuli to the ulnar nerve and recording electromyography (EMG) responses from the adductor pollicis muscle. Surface hydrogel electrodes with adhesive foam ensure secure placement for continuous monitoring. The single-use sensor connects to a reusable NMT Cable and is designed for use with GE HealthCare NMT measurement devices (NMT Module and bedside monitors).

Interventions

DEVICECollection of NMT Technology

Collection and assessment of non-invasive electrical stimuli from the NMT measurement placed on the patient's hand and forearm to measure the level of neuromuscular blocking agents during standard of care surgical procedures.

Sponsors

GE Healthcare
Lead SponsorINDUSTRY
Loma Linda University
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Study subject (male or female) is age 18 years or older (≥18 years). 2. Study subject must have the ability to understand and provide written informed consent. 3. Study subject is undergoing a clinically indicated procedure requiring the use of paralytic medication. 4. Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand/forearm.

Exclusion criteria

1. Are known to be pregnant. 2. Are breastfeeding. 3. Suffering from an infection(s) that requires isolation. 4. Deformity, scar tissue, tattoos, or other characteristics at the sensor application area that could interfere (e.g., nerve damage) with the completion of the study procedure or identify a study subject. 5. Subjects requiring rapid sequence induction 6. Subjects expected to be at risk from participation for any reason, such as those with known allergy or sensitivity to adhesive materials that may be used in the study. 7. Direct employees or contractors of GE HealthCare, or any company that makes NMT monitoring devices (sensors, cables, modules). 8. NMT ElectroSensor placed on the foot/ankle

Design outcomes

Primary

MeasureTime frameDescription
Collection of End User Feedback SurveysUp to 24 hoursCollection of end user feedback surveys on the functionality and clinical use of the NMT Sensor and Cable during standard of care surgical procedure (minimum of 1 hour and maximum of 24 hours).

Secondary

MeasureTime frameDescription
Collection of raw parameter data from NMT Sensor and CableUp to 24 hoursCollection of raw parameter data from NMT Sensor and Cable to evaluate the reliability of the measurements to NMBA concordance rate.
Incidence of Safety Events4 months.Analysis of adverse events will be listed per subject, summarized with counts and percentages of events, and summarized with counts and percentages of subjects with events.

Countries

United States

Contacts

CONTACTMelissa McCabe, MD
mmccabe@llu.edu909-558-4475

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 9, 2026